Related Experiment Video

Updated: Aug 11, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

[Hypothyroidism and myocardial damage in cardiac donors]

J López Haldón1, Martínez Martínez A, A Ordóñez

  • 1Servicios de Cardiología ospital San Sebastián, Ecija, Hospital Universitario Virgen del Rocío, Sevilla. lhaldon@interbook.net

Revista Espanola De Cardiologia
|June 20, 2001
PubMed

Insights

Hypothyroidism and myocardial damage are frequent in brain dead organ donors. However, this study found no correlation between these two conditions, suggesting they are independent issues.

Area of Science:

  • Cardiology
  • Endocrinology
  • Transplantation Science

Context:

  • Brain death can lead to myocardial contractile dysfunction and hypothyroidism, impacting donor heart viability.
  • Myocardial damage is implicated in contractile dysfunction in brain dead donors.
  • Hypothyroidism is a known contributor to cardiovascular issues in brain dead individuals.

Purpose:

  • To quantify myocardial damage and thyroid status in cardiac donors.
  • To analyze the potential correlation between hypothyroidism and myocardial damage in brain death.

Summary:

  • Serum samples from 45 cardiac donors were analyzed for cardiac troponins (myocardial damage markers) and thyroid hormones.
  • Elevated cardiac troponins were found in 42.2% of donors.
  • Hypothyroidism was highly prevalent, detected in 86.7% of donors, with no observed correlation to myocardial damage markers.

Impact:

  • Highlights the high incidence of both hypothyroidism and myocardial damage in brain dead donors.
  • Demonstrates that hypothyroidism and myocardial damage in brain death are not associated.
  • Informs transplantation protocols by clarifying the independent nature of these two common findings in organ donors.
Abstract

More Related Videos

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Study of Experimental Organ Donation Models for Lung Transplantation08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...